HCWCHIGH SIGNALRISK10-K

HCWC faces heightened liquidity concerns with outstanding funding commitments of $8.0 million from institutional investors being repeatedly delayed, now pushed to April 2027, accompanied by deteriorating operating losses.

The company's reliance on external funding commitments that have been amended multiple times raises serious questions about financial stability and investor confidence. The reference to going concern considerations in Note 2, combined with worsening operating performance, suggests meaningful execution challenges that could impact the company's ability to continue operations without the delayed funding.

Comparing 2026-03-16 vs 2025-03-28View on EDGAR →
FINANCIAL ANALYSIS

HCWC showed mixed financial results with revenue growing modestly to $78.2M and gross profit expanding to $30.7M, indicating some underlying business momentum. However, operating losses deepened meaningfully while SG&A expenses increased 14.1%, suggesting cost control challenges that offset revenue gains. The balance sheet showed improvement with debt reduction of 36% and higher cash balances, though this positive development is overshadowed by the funding commitment delays and going concern implications.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+43.8%
$2.1M→$3.0M

Cash position surged 43.8% — strong cash generation or capital raise providing significant financial cushion.

Operating Income
P&L
-39.8%
-$1.8M→-$2.5M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Total Debt
Balance Sheet
-35.6%
$11.3M→$7.3M

Debt reduced 35.6% — deleveraging strengthens balance sheet and reduces financial risk.

Accounts Receivable
Balance Sheet
-28.6%
$510K→$364K

Receivables declined — improved collection efficiency or conservative revenue recognition.

Capital Expenditure
Cash Flow
+27.3%
$252K→$321K

Capex increased 27.3% — ongoing investment in capacity or infrastructure for future growth.

Total Liabilities
Balance Sheet
-17.5%
$31.7M→$26.2M

Liabilities reduced 17.5% — deleveraging improves balance sheet strength and financial flexibility.

SG&A Expense
P&L
+14.1%
$29.0M→$33.1M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Gross Profit
P&L
+13.3%
$27.1M→$30.7M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Revenue
P&L
+12.7%
$69.4M→$78.2M

Revenue growing 12.7% — solid top-line momentum, watch margins for quality of growth.

Net Income
P&L
+12.7%
-$4.5M→-$3.9M

Net income grew 12.7% — bottom-line growth signals improving overall business health.

LANGUAGE CHANGES
NEW — 2026-03-16
PRIOR — 2025-03-28
ADDED
Exhibits, Financial Statement Schedules 28 Exhibit Index 29 SIGNATURES 31 i PART I Item 1.
On October 30, 2025, the parties to the HCMC Series E SPA entered into a Ninth Amendment to HCMC Series E SPA, pursuant to which HCMC and such parties agreed to amend the Completion Date to April 1, 2027.
As of December 31, 2025, HCWC has received $5.25 million of the committed $13.25 million, leaving the contractually obligated $8.0 million binding commitments to be fulfilled.
The parties, which comprise of the institutional investors that participated in the Spin-off as described above, have communicated their intent to further extend the Completion Date.
For further details regarding the remaining $8.0 million commitment and its significance to the Company s liquidity, see Note 2 - Going Concern.
+7 more — sign up free →
REMOVED
Exhibits, Financial Statement Schedules 27 Exhibit Index 28 SIGNATURES 30 PART I Item 1.
For the years ended December 31, 2024 and 2023, approximately 25% and 41% of our total purchases were from one vendor.
Existing unredeemed loyalty points remain valid for redemption until January 31, 2025.
Our Employees As of December 31, 2024, HCWC employed approximately 450 employees across its retail, warehouse, and corporate operations.
The Company s operations are managed as one integrated business unit with similar economic characteristics and are similar in the nature of the products sold, the product acquisition process, the types of customers products are sold to, the methods used to distribute the products, and the nature of the regulatory environment.
+7 more — sign up free →
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →